残留胆固醇变化与糖尿病发病率:两项大型前瞻性队列研究的结果。

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Yue Shao, Zhenghao Li, Min Sun, Qingchen Wu, Haoming Shi, Liu Ye
{"title":"残留胆固醇变化与糖尿病发病率:两项大型前瞻性队列研究的结果。","authors":"Yue Shao, Zhenghao Li, Min Sun, Qingchen Wu, Haoming Shi, Liu Ye","doi":"10.1111/dom.16383","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study seeks to analyse the effect of the change and accumulation of residual cholesterol (RC) on the risk of diabetes.</p><p><strong>Methods: </strong>The analysis included 5124 participants from the China Health and Retirement Longitudinal Study (CHARLS) and 2704 participants from the English Longitudinal Study of Ageing (ELSA), all of whom underwent two repeated RC measurements. Changes in the RC were assessed through K-means clustering analysis, and the cumulative RC was determined using the formula: by (RC<sub>first</sub> + RC<sub>second</sub>)/2 × (time interval between first and second assessments). We employed Cox proportional hazards regression models to analyse the effect of the changes and accumulation of RC on the development of diabetes.</p><p><strong>Results: </strong>Individuals with consistently elevated RC levels (class 4) demonstrated a 1.98-fold increase in diabetes risk 95% confidence interval (CI: 1.38-2.84) in the CHARLS study and a 2.73-fold increase (95% CI: 1.69-4.38) in the ELSA study, compared with those with consistently low RC levels (class 1). Similarly, the risk of diabetes increased by 1.62 (95% CI: 1.21-2.18) times in CHARLS and 2.98 (95% CI: 1.81-4.88) folds in ELSA for participants with highest levels of cumulative RC relative to those with lowest levels of cumulative RC. Elevated cumulative RC remains a substantial risk factor for diabetes, irrespective of the cumulative LDL-C level.</p><p><strong>Conclusions: </strong>Long-term exposure to high RC levels links to an elevated risk of diabetes. Therefore, maintaining optimal RC levels and continuously monitoring them may contribute to reducing the incidence of diabetes.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies.\",\"authors\":\"Yue Shao, Zhenghao Li, Min Sun, Qingchen Wu, Haoming Shi, Liu Ye\",\"doi\":\"10.1111/dom.16383\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study seeks to analyse the effect of the change and accumulation of residual cholesterol (RC) on the risk of diabetes.</p><p><strong>Methods: </strong>The analysis included 5124 participants from the China Health and Retirement Longitudinal Study (CHARLS) and 2704 participants from the English Longitudinal Study of Ageing (ELSA), all of whom underwent two repeated RC measurements. Changes in the RC were assessed through K-means clustering analysis, and the cumulative RC was determined using the formula: by (RC<sub>first</sub> + RC<sub>second</sub>)/2 × (time interval between first and second assessments). We employed Cox proportional hazards regression models to analyse the effect of the changes and accumulation of RC on the development of diabetes.</p><p><strong>Results: </strong>Individuals with consistently elevated RC levels (class 4) demonstrated a 1.98-fold increase in diabetes risk 95% confidence interval (CI: 1.38-2.84) in the CHARLS study and a 2.73-fold increase (95% CI: 1.69-4.38) in the ELSA study, compared with those with consistently low RC levels (class 1). Similarly, the risk of diabetes increased by 1.62 (95% CI: 1.21-2.18) times in CHARLS and 2.98 (95% CI: 1.81-4.88) folds in ELSA for participants with highest levels of cumulative RC relative to those with lowest levels of cumulative RC. Elevated cumulative RC remains a substantial risk factor for diabetes, irrespective of the cumulative LDL-C level.</p><p><strong>Conclusions: </strong>Long-term exposure to high RC levels links to an elevated risk of diabetes. Therefore, maintaining optimal RC levels and continuously monitoring them may contribute to reducing the incidence of diabetes.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.16383\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16383","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在分析残余胆固醇(RC)的变化和积累对糖尿病风险的影响。方法:分析包括来自中国健康与退休纵向研究(CHARLS)的5124名参与者和来自英国老龄化纵向研究(ELSA)的2704名参与者,所有参与者都进行了两次重复的RC测量。通过K-means聚类分析评估RC的变化,累积RC采用公式(RCfirst + RCsecond)/2 ×(第一次和第二次评估之间的时间间隔)确定。我们采用Cox比例风险回归模型分析RC的变化和积累对糖尿病发展的影响。结果:与RC水平持续升高的个体(第4类)相比,在CHARLS研究中,RC水平持续升高的个体(第4类)患糖尿病的风险增加了1.98倍,95%置信区间(CI: 1.38-2.84),在ELSA研究中增加了2.73倍(95% CI: 1.69-4.38)。同样,在CHARLS研究中,糖尿病的风险增加了1.62倍(95% CI: 1.21-2.18),在CHARLS研究中增加了2.98倍(95% CI: 2.98)。累积RC水平最高的参与者的ELSA是累积RC水平最低的参与者的1.81-4.88倍。无论累积LDL-C水平如何,升高的累积RC仍然是糖尿病的重要危险因素。结论:长期暴露于高水平的RC与糖尿病风险升高有关。因此,维持最佳的RC水平并持续监测可能有助于降低糖尿病的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies.

Objective: This study seeks to analyse the effect of the change and accumulation of residual cholesterol (RC) on the risk of diabetes.

Methods: The analysis included 5124 participants from the China Health and Retirement Longitudinal Study (CHARLS) and 2704 participants from the English Longitudinal Study of Ageing (ELSA), all of whom underwent two repeated RC measurements. Changes in the RC were assessed through K-means clustering analysis, and the cumulative RC was determined using the formula: by (RCfirst + RCsecond)/2 × (time interval between first and second assessments). We employed Cox proportional hazards regression models to analyse the effect of the changes and accumulation of RC on the development of diabetes.

Results: Individuals with consistently elevated RC levels (class 4) demonstrated a 1.98-fold increase in diabetes risk 95% confidence interval (CI: 1.38-2.84) in the CHARLS study and a 2.73-fold increase (95% CI: 1.69-4.38) in the ELSA study, compared with those with consistently low RC levels (class 1). Similarly, the risk of diabetes increased by 1.62 (95% CI: 1.21-2.18) times in CHARLS and 2.98 (95% CI: 1.81-4.88) folds in ELSA for participants with highest levels of cumulative RC relative to those with lowest levels of cumulative RC. Elevated cumulative RC remains a substantial risk factor for diabetes, irrespective of the cumulative LDL-C level.

Conclusions: Long-term exposure to high RC levels links to an elevated risk of diabetes. Therefore, maintaining optimal RC levels and continuously monitoring them may contribute to reducing the incidence of diabetes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信